ro 5-4864 has been researched along with thapsigargin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, DG; Castaldi, MP; Dekker, N; Hermansson, NO; Kawatkar, A; Lundbäck, T; Schefter, M; Snijder, A; Zhang, AX | 1 |
1 other study(ies) available for ro 5-4864 and thapsigargin
Article | Year |
---|---|
CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins.
Topics: Aminoquinolines; Benzamides; Benzimidazoles; Benzodiazepinones; Benzodioxoles; Benzyl Alcohols; Biological Assay; Cell Line, Tumor; GABA Antagonists; HEK293 Cells; Hot Temperature; Humans; Imidazoles; Phase Transition; Protein Multimerization; Pyridines; Receptor, PAR-2; Receptors, GABA; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin | 2019 |